Selective photocoagulation in Coats' disease

Ten-year follow-up

P. Nucci, F. Bandello, M. Serafino, M. E. Wllson

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

PURPOSE. The diagnostic hallmark of Coats' disease is development of "light bulb" telangiectasis in the retinal periphery, leading to posterior pole intraretinal and subretinal exudation. Even after complete obliteration of all abnormal vessels and resorption of all exudates, follow-up examinations are mandatory for several years. METHODS. We retrospectively analyzed the charts, pictures and/or fluorescein angiographies of a series of 32 consecutive patients, in which the diagnosis of Coats' disease was made. All patients underwent selective photocoagulation of the telangiectasis using a yellow-dye laser. Efficacy of treatment was monitored with drawings and/or fluorescein angiographies. RESULTS. All our patients had unilateral disease, with macular involvement and exudative retinal detachment. Visual acuity improved in one patient, decreased from light perception to blindness in another, and was unchanged in the remainder. CONCLUSIONS. This is the first report of anatomical benefits from treatment with a yellow-dye laser (i.e., selective photocoagulation without cryotherapy or drainage) despite the presence of a severe form of Coats' disease. Our young Coats' patients responded quickly to treatment. With successful obliteration of the abnormal vasculature, exudates began to absorb in about 4 to 8 weeks although, in some cases, 10 to 12 months were needed to obtain resolution of the exudative detachment. Poor visual outcome of 20/100 or worse was common. In Coats' patients, the key issue is continuous control and long-term follow-up.

Original languageEnglish
Pages (from-to)501-505
Number of pages5
JournalEuropean Journal of Ophthalmology
Volume12
Issue number6
Publication statusPublished - Nov 2002

Fingerprint

Retinal Telangiectasis
Light Coagulation
Dye Lasers
Fluorescein Angiography
Exudates and Transudates
Light
Telangiectasis
Cryotherapy
Retinal Detachment
Blindness
Visual Acuity
Drainage
Therapeutics

Keywords

  • Coats' disease
  • Dye yellow laser
  • Photocoagulation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Selective photocoagulation in Coats' disease : Ten-year follow-up. / Nucci, P.; Bandello, F.; Serafino, M.; Wllson, M. E.

In: European Journal of Ophthalmology, Vol. 12, No. 6, 11.2002, p. 501-505.

Research output: Contribution to journalArticle

Nucci, P, Bandello, F, Serafino, M & Wllson, ME 2002, 'Selective photocoagulation in Coats' disease: Ten-year follow-up', European Journal of Ophthalmology, vol. 12, no. 6, pp. 501-505.
Nucci, P. ; Bandello, F. ; Serafino, M. ; Wllson, M. E. / Selective photocoagulation in Coats' disease : Ten-year follow-up. In: European Journal of Ophthalmology. 2002 ; Vol. 12, No. 6. pp. 501-505.
@article{b60cf348683e472685b61192ef80af3c,
title = "Selective photocoagulation in Coats' disease: Ten-year follow-up",
abstract = "PURPOSE. The diagnostic hallmark of Coats' disease is development of {"}light bulb{"} telangiectasis in the retinal periphery, leading to posterior pole intraretinal and subretinal exudation. Even after complete obliteration of all abnormal vessels and resorption of all exudates, follow-up examinations are mandatory for several years. METHODS. We retrospectively analyzed the charts, pictures and/or fluorescein angiographies of a series of 32 consecutive patients, in which the diagnosis of Coats' disease was made. All patients underwent selective photocoagulation of the telangiectasis using a yellow-dye laser. Efficacy of treatment was monitored with drawings and/or fluorescein angiographies. RESULTS. All our patients had unilateral disease, with macular involvement and exudative retinal detachment. Visual acuity improved in one patient, decreased from light perception to blindness in another, and was unchanged in the remainder. CONCLUSIONS. This is the first report of anatomical benefits from treatment with a yellow-dye laser (i.e., selective photocoagulation without cryotherapy or drainage) despite the presence of a severe form of Coats' disease. Our young Coats' patients responded quickly to treatment. With successful obliteration of the abnormal vasculature, exudates began to absorb in about 4 to 8 weeks although, in some cases, 10 to 12 months were needed to obtain resolution of the exudative detachment. Poor visual outcome of 20/100 or worse was common. In Coats' patients, the key issue is continuous control and long-term follow-up.",
keywords = "Coats' disease, Dye yellow laser, Photocoagulation",
author = "P. Nucci and F. Bandello and M. Serafino and Wllson, {M. E.}",
year = "2002",
month = "11",
language = "English",
volume = "12",
pages = "501--505",
journal = "European Journal of Ophthalmology",
issn = "1120-6721",
publisher = "Wichtig Publishing",
number = "6",

}

TY - JOUR

T1 - Selective photocoagulation in Coats' disease

T2 - Ten-year follow-up

AU - Nucci, P.

AU - Bandello, F.

AU - Serafino, M.

AU - Wllson, M. E.

PY - 2002/11

Y1 - 2002/11

N2 - PURPOSE. The diagnostic hallmark of Coats' disease is development of "light bulb" telangiectasis in the retinal periphery, leading to posterior pole intraretinal and subretinal exudation. Even after complete obliteration of all abnormal vessels and resorption of all exudates, follow-up examinations are mandatory for several years. METHODS. We retrospectively analyzed the charts, pictures and/or fluorescein angiographies of a series of 32 consecutive patients, in which the diagnosis of Coats' disease was made. All patients underwent selective photocoagulation of the telangiectasis using a yellow-dye laser. Efficacy of treatment was monitored with drawings and/or fluorescein angiographies. RESULTS. All our patients had unilateral disease, with macular involvement and exudative retinal detachment. Visual acuity improved in one patient, decreased from light perception to blindness in another, and was unchanged in the remainder. CONCLUSIONS. This is the first report of anatomical benefits from treatment with a yellow-dye laser (i.e., selective photocoagulation without cryotherapy or drainage) despite the presence of a severe form of Coats' disease. Our young Coats' patients responded quickly to treatment. With successful obliteration of the abnormal vasculature, exudates began to absorb in about 4 to 8 weeks although, in some cases, 10 to 12 months were needed to obtain resolution of the exudative detachment. Poor visual outcome of 20/100 or worse was common. In Coats' patients, the key issue is continuous control and long-term follow-up.

AB - PURPOSE. The diagnostic hallmark of Coats' disease is development of "light bulb" telangiectasis in the retinal periphery, leading to posterior pole intraretinal and subretinal exudation. Even after complete obliteration of all abnormal vessels and resorption of all exudates, follow-up examinations are mandatory for several years. METHODS. We retrospectively analyzed the charts, pictures and/or fluorescein angiographies of a series of 32 consecutive patients, in which the diagnosis of Coats' disease was made. All patients underwent selective photocoagulation of the telangiectasis using a yellow-dye laser. Efficacy of treatment was monitored with drawings and/or fluorescein angiographies. RESULTS. All our patients had unilateral disease, with macular involvement and exudative retinal detachment. Visual acuity improved in one patient, decreased from light perception to blindness in another, and was unchanged in the remainder. CONCLUSIONS. This is the first report of anatomical benefits from treatment with a yellow-dye laser (i.e., selective photocoagulation without cryotherapy or drainage) despite the presence of a severe form of Coats' disease. Our young Coats' patients responded quickly to treatment. With successful obliteration of the abnormal vasculature, exudates began to absorb in about 4 to 8 weeks although, in some cases, 10 to 12 months were needed to obtain resolution of the exudative detachment. Poor visual outcome of 20/100 or worse was common. In Coats' patients, the key issue is continuous control and long-term follow-up.

KW - Coats' disease

KW - Dye yellow laser

KW - Photocoagulation

UR - http://www.scopus.com/inward/record.url?scp=0036877582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036877582&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 501

EP - 505

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

SN - 1120-6721

IS - 6

ER -